|
|
|
| |
Educational Resources
To serve the patient community, we have prepared general information on certain diseases for which Hemispherx, or its partners, have research programs underway, or have conducted preliminary clinical trials in the United States. To complement this information we have provided relevant references to useful resource sites at the bottom of each page. Please visit this page periodically as facts on additional information may be added. See the links to the right for information on Chronic Fatigue Syndrome, HIV, hepatitis B, hepatitis C, renal cell carcinoma, and metastatic malignant melanoma.
|
|
Information contained on the Hemispherx website other than historical information, should be considered forward-looking and is subject to various risk factors and uncertainties. For instance, the strategies and operations of Hemispherx involve risks of competition, changing market conditions, changes in laws and regulations affecting these industries and numerous other factors discussed on the Hemispherx website and in the Company's filings with the Securities and Exchange Commission. Accordingly, actual results may differ materially from those in any forward-looking statements. Additionally, all the referenced investigational drugs and associated technologies of the company are experimental in nature and as such are not designated safe and effective by a regulatory authority for general use and are legally available only through clinical trials with the referenced disorders. The forward-looking statements represent the Company's judgement as of the date of this website. The Company disclaims, however, any intent or obligation to update these forward-looking statements. |
|
